Among the highest performers were multiple facilities in Nashville, Middle Tennessee and surrounding communities.
Raleigh, NC - March 16, 2026 - PRESSADVANTAGE - Porter Ophthalmology has opened a dedicated Office-Based Surgery suite ...
Alcon and Lensar are walking away from a proposed acquisition deal following pushback from the Federal Trade Commission (FTC) ...
Lensar is known for developing the Ally robotic cataract laser treatment system, alongside Streamline software technology and ...
HelpMeSee Featured in 'Healthier Together,' Presented by the WHO Foundation, Highlighting Efforts to Reduce Cataract Blindness Through Surgical Training ...
The Tecnis PureSee IOL is the first FDA-approved extended depth of focus IOL maintaining contrast sensitivity comparable to ...
US News evaluated freestanding ASCs only, excluding hospital-affiliated outpatient departments to avoid overlap with hospital rankings and maintain comparability across facility types. Methodology ...
Alcon and Lensar terminate merger due to FTC challenges. Lensar retains a $10M deposit and focuses on Ally laser growth. More updates on March 31.
Johnson & Johnson (NYSE:JNJ) received FDA approval for its TECNIS PureSee IOL, an extended depth of focus intraocular lens ...
ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the ...
At 12 months in a phase 1/2 trial, the Bimatoprost Drug Pad-IOL System improved IOP, vision and treatment burden in patients ...
Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results